Medicamen Biotech Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 217.76 million compared to INR 246.214 million a year ago. Net income was INR 36.469 million compared to INR 24.933 million a year ago. Basic earnings per share from continuing operations was INR 2.99 compared to INR 2.05 a year ago. For the full year, total revenue was INR 1,134.701 million compared to INR 1,274.426 million a year ago. Net income was INR 121.294 million compared to INR 132.912 million a year ago. Basic earnings per share from continuing operations was INR 9.93 compared to INR 10.94 a year ago.